FREE SHIPPING ON ORDERS OVER $200 · FOR RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

Research library Comparisons

BPC-157 Acetate vs BPC-157 Arginate: What the Salt Form Changes

Article

Comparisons · 3 MIN READ · COMPARISON

01 / Overview

Same peptide, different counterion

BPC-157 acetate and BPC-157 arginate contain the same 15-residue peptide. They differ in the counterion, the small molecule that balances the charges on the peptide in the solid. Acetate, from acetic acid at about 60 Da per equivalent, is the standard counterion for research peptides after purification. Arginate uses L-arginine, at about 174 Da per equivalent, and is marketed mainly as a more stable form for oral products.

What is a counterion?

Synthetic peptides are purified as salts. Charged groups on the peptide, here the N-terminal amine and the lysine side chain, pair with oppositely charged counterions. Trifluoroacetate is left over from synthesis and purification; it is usually exchanged for acetate. The counterion is part of the weighed powder but is not part of the peptide.

How does the counterion affect the amount of peptide?

A heavier counterion takes up more of the weight. With one equivalent of counterion, peptide accounts for about 95.9 percent of the salt's weight as an acetate and about 89.1 percent as an arginate, before water is considered. More counterion equivalents lower those figures further. That is why net peptide content, the actual mass of peptide per vial, is the meaningful figure when comparing salt forms.

Is the arginate form more stable?

The stability claim originates mainly with suppliers of oral formulations. Peer-reviewed studies directly comparing the stability of BPC-157 acetate and arginate are scarce, and most of the BPC-157 literature does not specify the arginate form [1]. Claims about stability should be supported by stability data for the specific form.

How are they distinguished in the laboratory?

The peptide gives the same mass in both forms, so mass spectrometry of the peptide alone does not distinguish them. Ion chromatography or nuclear magnetic resonance can identify and quantify the counterion, and impurity profiling practices for peptide medicines include counterion content as a parameter [2].

Frequently asked questions

Does 10 mg of BPC-157 arginate contain 10 mg of peptide?

Not necessarily. It depends on whether the label states the weight of the salt or the weight of the peptide. Only the net peptide content answers the question.

Which form does FLASK list?

FLASK lists BPC-157 in its standard form; the batch record states the method and reserves a field for net peptide content when the laboratory report includes it.

Key facts

  • Peptide BPC-157, GEPPPGKPADDAGLV · 1419.5 Da
  • Acetate counterion Acetic acid, 60.05 Da per equivalent
  • Arginate counterion L-arginine, 174.2 Da per equivalent
  • Effect A heavier counterion lowers the share of peptide in the weighed powder

Footnotes & references

Source list

References

  1. Seiwerth S et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021;12:627533. PMID: 34267654.
  2. D'Hondt M et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PMID: 25044089.

Related products & records

Read the specification and the record

Use the lot record and testing pages for the source analytical documentation.

Related reading

Continue through the library

Related reading

What Is BPC-157? Structure, Sequence and Naming Conventions

Topic hub

Open topic